4.3 Article

Diabetes, peripheral neuropathy, and lower-extremity function

Journal

JOURNAL OF DIABETES AND ITS COMPLICATIONS
Volume 28, Issue 1, Pages 91-95

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jdiacomp.2013.08.007

Keywords

Gerontology; Geriatrics; Peripheral neuropathy; Lower extremity function

Funding

  1. Italian Ministry of Health [ICS 110.1\RS97.71]
  2. Intramural Research Program of the National Institute on Aging, NIH [N01-AG-916413, N01-AG-821336, N01-AG-5-0002]

Ask authors/readers for more resources

Objective: Diabetes among older adults causes many complications, including decreased lower-extremity function and physical disability. Diabetes can cause peripheral nerve dysfunction, which might be one pathway through which diabetes leads to decreased physical function. The study aims were to determine the following: (1) whether diabetes and impaired fasting glucose are associated with objective measures of physical function in older adults, (2) which peripheral nerve function (PNF) tests are associated with diabetes, and (3) whether PNF mediates the diabetes-physical function relationship. Research Design and Methods: This study included 983 participants, age 65 years and older from the InCHIANTI study. Diabetes was diagnosed by clinical guidelines. Physical performance was assessed using the Short Physical Performance Battery (SPPB), scored from 0 to 12 (higher values, better physical function) and usual walking speed (m/s). PNF was assessed via standard surface electroneurographic study of right peroneal nerve conduction velocity, vibration and touch sensitivity. Clinical cutpoints of PNF tests were used to create a neuropathy score from 0 to 5 (higher values, greater neuropathy). Multiple linear regression models were used to test associations. Results and Conclusion: One hundred twenty-six (12.8%) participants had diabetes. Adjusting for age, sex, education, and other confounders, diabetic participants had decreased SPPB (beta = -0.99; p < 0.01), decreased walking speed (beta = -0.1 m/s; p < 0.01), decreased nerve conduction velocity (beta = -1.7 m/s; p < 0.01), and increased neuropathy (beta = 0.25; p < 0.01) compared to non-diabetic participants. Adjusting for nerve conduction velocity and neuropathy score decreased the effect of diabetes on SPPB by 20%, suggesting partial mediation through decreased PNF. (C) 2014 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available